Providing Ophthalmic Instruments and Accessories to the

Redwood City, CA—The first of 15 patients has received CGC-11047, a novel poly-amine analog that targets choroidal neovascularization associated with age-related macular degeneration. (Source: Ophthalmology Times - Ophthalmic News)